Topic Archives: Rheumatoid Arthritis

Comments

  • Avatar

    I wanted to add my experience to the CBD oil efficacy comments. I tried two products purchased at a Colorado dispensary...

  • Avatar

    At 77 years old I have arthritis in my index fingers and other hand joints. My wife gave me a jar of CBD oil balm, and I...

  • Avatar

    David, could you send me some of the plants and herbs you grow for alternative medicine and please share some of your kn...

  • Avatar

    I have read that a lot of the immunotherapies have had fairly unpleasant side effects. A bit over 40% I believe. Especia...

  • SoGiAm

    #Vitamin D may help prevent rheumatoid arthritis, suggests study https://twitter.com/guardian/status/932868575693598720 ...

  • Avatar

    Ablynx $ABLX (ADR 1-for-1) $20.87 Market Cap $1.573B Belgium Based A couple of years ago nocitons and sogiam were ...

  • Avatar

    After viewing the 7 part of the Sacred Plant, I changed my views on cannabis. The medical properties have made a huge d...

  • Dr. KSS MD PhD

    As most readers know, science is on a tear with recent discoveries about the fecal biome. It's unique in each of us, thr...

  • Avatar

    the problem with legalization IF you are A pothead is they make it too expensive. My neighbor has Rheumatoid Arthritis A...

  • Avatar

    Rheumatoid Arthritis is something I have been living with for many years,something that helps reduce the pain is Green L...

  • Avatar

    $INCY $LLY No position, but thought I'd post because it is a stock that has been owned and discussed by our group. Th...

  • Avatar

    $AUPH long. So, I just got off shift, and I had a patient with Lupus Nephritis. She came in complaining of low back p...

  • Avatar

    http://www.medicinenet.com/auranofin/article.htm In 1982 my engineering firm was involved in the design of the manufact...

  • Avatar

    NSAID side effect study results are in! A ten year, 24,000 patient study at the Cleveland Clinic has addressed safety c...

  • SoGiAm

    J&J has grabbed an option to buy Bird Rock Bio and its experimental NASH drug candidate, the CB1-targeting antibody ...

  • Vijay

    $INCY Incyte Corporation (INCY) a likely takeover target for Gilead Sciences, Inc. (GILD) Published By News Desk ...

  • Avatar

    PDUFA dates in January, 2017. Highlights: (excerpted and edited) (1) $ANAC: Anacor Pharmaceuticals's PDUFA Date: Jan...

  • SoGiAm

    Current rheumatoid arthritis data this weekend and near future: https://endpts.com/jj-gsk-stumble-coming-out-of-the-gat...

  • Avatar

    $INCY Long New data from pivotal RA-BEACON study show significant improvement in patient-reported outcomes in rheumat...

  • SoGiAm

    Not a cure but possible treatment, imo - Ben A single course of treatment will provide relief from crippling pain and j...

  • Avatar

    $GILD (just in): Gilead scraps a PhII/III study early as drug flops against ulcerative colitis by john carroll Sept...

  • Avatar

    $GILD $GLPG: Gilead tackles a big PhIII program for blockbuster hopeful filgotinib, acquired from Galapagos (GLPG) mo...

  • Avatar

    Doc, I have a question for you (with the warning that I know next to nothing about the subject). The question is easier ...

  • Avatar

    $CCXI Reading thru the full data set its obvious; CCX168 is a stellar drug. I beats standard of care on every measure...

  • Dr. KSS MD PhD

    Because a man with a computer, a protocol, an imagination and a cheap-trick IRB is a man with a lock patent on random di...

  • Avatar

    $PFE FDA approves once daily oral Xeljanz for methotrexate resistant Rheumatoid Arthritis!!! If this is as effective ...

  • Michael Jorrin (aka Doc Gumshoe)

    Many thanks for all the comments. Here are a few comments on the comments, which I hope will be helpful. To Rich B...

  • Avatar

    As posted yesterday by Frank, new research from MIT, the University of Massachusetts Medical School, the University of C...

  • Avatar

    $ABBV Again from ETF Channel, AbbVie is a research-based biopharmaceutical company that develops and markets therapies ...

  • Avatar

    Another great article. Rekindles in me the question of why is Rheumatoid Arthritis three times more prevalent in women t...

  • sogiam

    PFE- Pfizer Gets U.S. Approval to Acquire Hospira, With Divestitures >PFE HSP Today 8:25 AM ET (Dow Jones)Print By Chel...

  • Avatar

    $TGXSF Tigenix – a Brussels based Biotech. They have a Phase III trial for Cx601 an adipose-derived allogeneic stem...

  • Avatar

    $TGXSF Tigenix - a Brussels based Biotech. They have a Phase III trial for Cx601 an adipose-derived allogeneic stem c...

  • Dr. KSS, MD PhD

    Glenn and Om had recently brought up Momenta as a play on the biosimilars space. What are biosimilars? They can be...

  • Anamorph

    To quote a great movie character, 'a man's got to know his limitations,' and I certainly can't analyze the science of an...

  • Avatar

    $CCXI On the plus side, CCXI is certainly not a one-trick pony (so binary event is not a stopper). Pipeline includes: ...

  • sogiam

    4 More Biotech Secondaries Investors Are Watching 12:50p ET January 7, 2015 (Benzinga) Print After Wednesday's close, ...

  • Dr. KSS, MD PhD

    Hi Matt..I am presuming you mean $REGN? ($RGEN is Repligen). I can see no real reason not to enthuse about it, though I ...

  • Avatar

    One I find interesting and has a lot of catalysts coming up especially their CF-102 drug for psoriasis and rheumatoid ar...

  • Avatar

    From the headlines, I thought the stock was Antares Pharma (ATRS), but then as I read the clues, figured it it wasn't. ...

  • om sharma

    Dr Bonz - I have a question for you, what is the best possible therapy/treatment available for Rheumatoid Arthritis. My...

  • Avatar

    FYI - Received this on 8/1/2014 Dear Stellar Biotechnologies’ Supporter: Below are links to stories released last we...

  • Dr. KSS, MD PhD

    There is a hypothesis, unproven, that greater bacterial diversity in the gut leads to better health. One of the probl...

  • Avatar

    Same here Doc - they have even compounds on the backburner for rheumatoid arthritis and osteoarthritis, and autism. But...

  • Dr. KSS, MD PhD

    Someone above was asking about Anthera Pharmaceuticals (ANTH). This company, if you take a long view of the chart, ha...

  • Avatar

    Can Pfizer's rheumatoid arthritis drug Xeljanz grow full head of hair on bald heads? http://blogs.wsj.com/pharmalot/2...

  • Avatar

    Doctor K and Lawrence, thumbs up on the postage and doing the heavy lifting. Doctor K, I looked at HZNP, looks like the...

  • Avatar

    Hi fellow Gumlanders, A Monday morning medical question for you. Does anyone have any experience with a drug called Me...

  • Dr. KSS, MD PhD

    playonwords: the kinds of probiotic supplements I am speaking of have many species of bacteria in great abundance. Yoghu...

  • Avatar

    According to Money Map Press, these bio stocks are on sale? Thoughts welcome... Profit Machine No. 1 Auspex Pharmaceu...

  • Dr. KSS, MD PhD

    Hi Glenn: About Antares, I hesitate. I notice that it does have 3 analysts with strong buy ratings and no other analysts...

  • Avatar

    Following up on Sovaldi/Gilead, means to paste this before: Here's entire WSJ article: http://tinyurl.com/l57mnfv "...

  • karmaswimswami

    Hi JustIrregular. Thanks for reading and posting. Colonoscopy is not perfect, but is very much here to stay. It is the o...

  • Avatar

    My mother had Alzheimer's, so I am motivated to try to avoid it. To date, I am aware of no efficacious drug. So I loo...

  • Avatar

    Again, apologies for my personal question that came out as a reply to #328. Oops. Moving forward - are there any opinio...

  • Avatar

    I work in an industry for which prediction of life span is important. One of the characteristics of rheumatoid arthritis...

  • Avatar

    I think they made this one a bit too easy. Just for fun, before I read any more than the clues, I Googled "cures for mul...

  • Avatar

    I have been following ACAD for the last three years, I have stock positions. They have a drug delivery system that is in...

  • This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

    Connect with Travis

    website designed by Gravity Switch